**7.7 Route 2: pacific region**

The *pfdhfr* CNRNI double mutant is predominant in malaria-endemic regions in the Pacific. The CNRNI has been reported to have two lineages, one which is indigenous and the other from Southeast Asia [92]. Resistance to pyrimethamine was observed in the early 1960s, after its introduction in a mass drug administration [68].
